Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau

PLoS ONE

Volumn 1, Issue 1, 2006, Pages

  Jensen, Mette Lundsby ^b   Dave, Sangeeta ^a   van der Loeff, Maarten Schim ^a   da Costa, Carlos ^b   Vincent, Tim ^a   Leligdowicz, Aleksandra ^a   Benn, Christine Stabell ^b   Roth, Adam ^b   Ravn, Henrick ^b   Lisse, Ida Maria ^c   Whittle, Hilton ^a   Aaby, Peter ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b Statens Serum Institut   (Guinea-Bissau)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINIA VACCINE; BCG VACCINE; SMALLPOX VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; FEMALE; GUINEA-BISSAU; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INJECTION SITE SCAR; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PREVALENCE; RURAL AREA; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; VACCINIA; AGED; COHORT ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; SCAR; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CICATRIX; COHORT STUDIES; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; SMALLPOX VACCINE;

EID: 34249901990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000101     Document Type: Article

References (34)

1. Mercer A (1990) Disease mortality and population in transition. Leicester: Leicester University Press. 262 p.
2. Henderson DA, Moss B (1999) Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, eds. VaccinesPhiladelphia: W.B.Saunders Company. pp. 74-97.
3. Aaby P, Samb B, Simondon F, Seck AM, Knudsen K, et al. (1995) Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 311: 481-485.
4. Kristensen I, Aaby P, Jensen H (2000) Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 321: 1435-1438.
5. Velema JP, Alihonou EM, Gandaho T, Hounye FH (1991) Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol 20: 474-479.
6. Gardy ML, Martins CL, Bale C, Balde MA, Hedegaard KL, et al. (2003) BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 21: 2782-2790.
7. Knudsen KM, Aaby P, Whittle H, Rowe M, Samb B, et al. (1996) Child mortality following standard, medium or high titre measles immunization in West Africa. Int J Epidemiol 25: 665-673.
8. Aaby P, Samb B, Simondon F, Knudsen K, Coll Seck AM, et al. (1993) Divergent mortality for male and female recipients of lowtitre and hightitre measles vaccines in rural Senegal. Am J Epidemiol 139: 716-755.
9. Ashorn P, Maleta K, Espo M, Kulmala T (2002) Male biased mortality among 1-2 year old children in rural Malami. Arch Dis Child 87: 386-387.
10. Aaby P, Gustafson P, Roth A, Rodrigues A, Fernandes M, et al, (2006) Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine 24: 5718-5725.
11. Wilkins A, Ricard D, Todd J, Whittle H, Dias F, et al. (1993) The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS 7: 1119-1122.
12. Ricard D, Wilkins A, NGum PT, Hayes R, Morgan G, et al. (1994) The effects of HIN-2 infection in a rural area of Guinea-Bissau. AIDS 8: 977-982.
13. Ariyoshi K, Berry N, Wilkins A, Ricard D, Aaby P, et al. (1996) A community-based study of HIV-2 provirus load in a rural village in West Africa. JID 173: 243-248.
14. Aaby P, Ariyoshi K, Buckner M, Jensen H, Berry N, et al. (1996) Age of wife as a major determinant of niale-to-female transmission of HIV-2 infection. A community study from rural West Africa. AIDS 10: 1585-1590.
15. Schim van der Loeff MF, Aaby P, Aryioshi K, Vincent T, Awasana. AA, et al. (2001) HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. AIDS 15: 2303-2310.
16. Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, et al. (2002) Low level viraemia and prolonged survival of HIV-2 infected villagers in rural Guinea-Bissau. AIDS Res Hum Retrovirol 18: 1167-1173.
17. Ariyoshi K, Berry N, Cham F, Jaffar S, Schim van der Loeff M, et al. (2003) Quantification of Human T-Lymphotropic Virus Type (HTLV-1) proviral load in rural West Africa population: no enhancement of Human Imummodeficiency Virus Type-2 pathogenesis but HTLV-1 proviral load relates to mortality. JID 188: 1648-1651.
18. Jaffar S, Schim van der Loeff M, Eugen-Olsen J, Vincent T, Sarje-Njie R, et al. (2005) Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau. Aids Res Hum Retrovirol 21: 560-564.
19. Cox DR, Oakes D (1984) Analysis of survival data. Londow Chapman & Hall. 208 p.
20. Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, et al. (2002) Doserelated effects of smallpox vaccine. N Engl J Med 346: 1275-1280.
21. Fine PEM, Ponninghaus JM, Maine N (1989) The distribution and implications of BCG scars in northern Malawi. Bull WHO 67: 35-42.
22. Poulsen AG, Aaby P, Jensen H, Dias F (2000) Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. ScandJ Infect Dis 32: 169-175.
23. Bager P, Westergaard T, Rostgaard K, Nielsen NM, Melbye M, et al. (2003) Smallpox vaccination and risk of allergy and asthma. J Allergy Clin Immunol 111: 1227-1231.
24. Kölmel KF, Gefeller O, Haferkamp B (1992) Febrile infections and malignant melanoma: results of a case-control study. Melanoma Res 2: 207-211.
25. Pfahlberg A, Kolmel KF, Grange JM, Mastrangelo G, Krone B, et al. (2002) Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. J Invest Dermatol 119: 570-575.
26. Grufferman S, Wang HH, DeLong ER, Kimm SY, Delzell ES, et al. (1982) Environmental factors in the etiology rhabdomyosarcoma in childhood.J Natl Cancer Inst 68: 107-113.
27. Gilat T, Hacohen D, Liles P, Langman MJ (1987) Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scan J Gastroenterol 22: 1009-1024.
28. Kurtzke JF, Hyllested K, Arbuckle JD, Brønnum-Hansen H, Wallin MT, et al. (1997) Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurol Scand 96: 149-157.
29. Kolmel KF, Grange JM, Krone B, Mastrangelo G, Rossi CR, et al. (2005) Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer 41: 118-125.
30. Demkowicz WE Jr, Littaua RA, Wang J, Ennis FA (1996) Human cytotoxic, T-cell memory. long-lived responses to vaccinia virus. J Virol 70: 2627-2631.
31. Demkowicz WE Jr, Ennis FA (1993) Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans. J Virol 66: 1538 1544.
32. Moore ZS, Seward JF, Lane JM (2006) Smallpox. Lancet 367: 425-435.
33. Sham F (2004) Heterologous immunity and the nonspecific effects of vaccines. A major medical advance? PIDJ 23: 555-558.
34. Welsh RM, Sein LK (2002) No one is naïve: the significance of heterologous T-cell immunity. Nat Rev Immunol 2: 417-426.